Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $0.1252W HIGH $0.89
Volume
8.28 K
Value Traded
4.69 K
Short % Float
0%
Days to Cover
1.0
+9.26%Week
-86.87%5 Year
-99.27%All Time
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
3.03 M
EPS (TTM)
-0.73
P/E Ratio
-
Ent. Value
-
Total Shares
7.16 M
Float Shares
4.73 M
Insiders
0.38%
Institutions
0.00%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
PoA blends historical approval base rates, trial design score and FDA review track record.
CYAN Catalyst Timeline
Dated clinical, regulatory and corporate events for Cyanotech Corporation
Past FDA Catalysts and PDUFA Decisions
How CYAN actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| No matching catalysts | ||||||
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
Clinical Trial Results
Readouts, endpoints and source filings for every CYAN program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Custer Matthew KeithDirector, Officer (President and CEO) | Option | 2,075 6,754 held | $0.00 | 07/29/2025 |
Hedge Fund 13F Activity
Hedge Funds invested in CYAN
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in CYAN for Q2 2026. | ||||
Ownership Trends
CYAN Short Interest
Shares sold short, counted twice a month.
0%
Short % of Float
of tradable shares sold short
2.3K
Shares Sold Short
+135.5% vs prior count
1.0 Low
Days to Cover
trading days of normal volume to buy every short share back
2.7K
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How CYAN ranks across every disease it competes in
Competitive Position is a premium feature
See how CYAN ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialCYAN News
CYANCyanotech Names Mawae Morton President
Cyanotech Names Mawae Morton President KAILUA KONA, Hawaii (July 17, 2017) - Cyanotech Corporation (Nasdaq Capital Market: CYAN) today announced that the Board of Directors has named Mawae Morton as President effective immediately. Mr. Morton will report directly to the Company'
Read more →CYANCyanotech Names Nancy Katz as a Director
News Release Contact: Bruce Russell (310) 346-6131 brussell@cyanotech.com Cyanotech Names Nancy Katz as a Director KAILUA KONA, Hawaii (October 25, 2016) - The Board of Directors of Cyanotech Corporation (Nasdaq Capital Market: CYAN) has named Nancy Katz as a Director of the
Read more →CYANCyanotech Names David Mulder as a Director
News Release Contact: Bruce Russell (310) 346-6131 brussell@cyanotech.com Cyanotech Names David Mulder as a Director KAILUA KONA, Hawaii (May 23, 2016) - The Board of Directors of Cyanotech Corporation (Nasdaq Capital Market: CYAN) named David Mulder as a Director of the Comp
Read more →CYANFounder Gerry Cysewski, Ph.D., Named Interim President & CEO of Cyanotech
News Release Contact: Bruce Russell (310) 346-6131 brussell@cyanotech.com Founder Gerry Cysewski, Ph.D., Named Interim President & CEO of Cyanotech KAILUA KONA, HAWAII (April 4, 2016) - Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leade
Read more →CYANCyanotech Names David L. Vied as a Director
Cyanotech Names David L. Vied as a Director KAILUA KONA, Hawaii (January 28, 2015) - David L. Vied of Los Angeles, CA has been elected as a Director by the Board of Directors of Cyanotech Corporation (Nasdaq Capital Market: CYAN). Mr. Vied was determined under Nasdaq rules to be
Read more →CYANCyanotech Reports Litigation Resolved
News Release Contact: Bruce Russell (310) 346-6131 brussell@cyanotech.com Cyanotech Reports Litigation Resolved KAILUA KONA, Hawaii (December 19, 2014) - Cyanotech Corporation (Nasdaq Capital Market: CYAN), today announced that all existing litigation and administrative proce
Read more →CYANCyanotech Names Gerry Watts as Chief Operations Officer
News Release Contact: Bruce Russell (310) 346-6131 brussell@cyanotech.com Cyanotech Names Gerry Watts as Chief Operations Officer KAILUA KONA, Hawaii (August 18, 2014) -Cyanotech Corporation (Nasdaq Capital Market: CYAN) has named Gerard "Gerry" Watts to fill a newly-created
Read more →CYANCyanotech Names Jole Deal as Chief Financial Officer
News Release Contact: Bruce Russell (310) 559-4955 x101 Cyanotech Names Jole Deal as Chief Financial Officer KAILUA KONA, Hawaii (August 17, 2011) Jole Deal has been appointed as Chief Financial Officer, Vice President of Finance and Administration, Treasurer and Secretary b
Read more →CYANCyanotech Names Thomas F. Chen as a Director
News Release Contact: Bruce Russell (310) 559-4955 x101 Cyanotech Names Thomas F. Chen as a Director KAILUA KONA, Hawaii (June 8, 2011) Thomas F. Chen of Lake Forest, Illinois has been elected as a Director by the Board of Directors of Cyanotech Corporation (Nasdaq Capital Mar
Read more →CYANCyanotech Names Ralph Carlton as a Director
News Release Contact: Bruce Russell (310) 559-4955 x101 Cyanotech Names Ralph Carlton as a Director KAILUA KONA, Hawaii (January 28, 2011) Ralph Carlton has been elected as Director by the Board of Directors of Cyanotech Corporation (Nasdaq Capital Market: CYAN). Mr. Carlton
Read more →CYANCyanotech Names Brent Bailey as President, Chief Executive Officer
News Release Contact: Bruce Russell (310) 559-4955 x101 brussell@cyanotech.com Cyanotech Names Brent Bailey as President, Chief Executive Officer and KONA, Hawaii (November 8, 2010) Cyanotech Corporation (Nasdaq Capital Market: CYAN) today announced that the Board of Dire
Read more →CYANCyanotech Chairman Gregg Robertson Resigns
News Release Contact: Bruce Russell (310) 559-4955 x101 brussell@cyanotech.com Cyanotech Chairman Gregg Robertson Resigns KONA, Hawaii (October 27, 2010) Cyanotech Corporation (Nasdaq Capital Market: CYAN) today announced that Gregg Robertson, age 76, Chairman of the Board
Read more →CYANCyanotech Director Jacobson Resigns
News Release Contact: Bruce Russell (310) 559-4955 x101 brussell@cyanotech.com Cyanotech Director Jacobson KAILUA KONA, Hawaii (April 5, 2010) Cyanotech Corporation (Nasdaq Capital Market: CYAN) announced that Andrew H. Jacobson submitted his resignation as a Director of
Read more →CYANCyanotech Receives Temporary Non-Compliance Notice from Nasdaq
News Release Contact: Bruce Russell (310) 559-4955 x101 brussell@cyanotech.com Cyanotech Receives Temporary Non-Compliance Notice from Nasdaq Related to Its Number of Independent Directors KAILUA KONA, Hawaii (March 12, 2010) Cyanotech Corporation (Nasdaq Capital Market:
Read more →CYANCyanotech s Board of Directors Names David I. Rosenthal as Interim President and CEO
News Release Contact: Bruce Russell (310) 559-4955 x101 brussell@cyanotech.com Cyanotech s Board of Directors Names David I. Rosenthal as Interim President and CEO KAILUA KONA, Hawaii (March 1, 2010) The Board of Directors of Cyanotech Corporation (Nasdaq Capital Market:
Read more →CYANCyanotech Names Deanna Spooner as
News Release Contact: Bruce Russell (310) 559-4955 x101 brussell@cyanotech.com Cyanotech Names Deanna Spooner as KAILUA KONA, Hawaii (October 31, 2008) Cyanotech Corporation (Nasdaq: CYAN), has named Deanna L. Spooner as Chief Financial Officer, effective November 14, 2008.
Read more →CYANCyanotech Reports Financial Results for the First Quarter of Fiscal 2009
News Release Contact: Bruce Russell (310) 559-4955 x101 brussell@cyanotech.com Cyanotech Reports Financial Results for the First Quarter of Fiscal 2009 KAILUA KONA, Hawaii (August 15, 2008) Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in producing
Read more →CYANCyanotech Names Andrew Jacobson as President & CEO Former Hain Personal Care President to Lead
News Release Contact: Bruce Russell 310-559-4955 x101 brussell@cyanotech.com Cyanotech Names Andrew Jacobson as President & CEO Former Hain Personal Care President to Lead New Marketing Initiative for Cyanotech s Leading Products, BioAstin Natural Astaxanthin and Spirul
Read more →CYANCyanotech Focuses Natural Astaxanthin Production on BioAstin® for Human Market, Discontinues Production of NatuRose® for Animal Feed Market in Strategic Move
News Release Contact: Bruce Russell (310) 559-4955 x101 brucerussell@ruscom.com Cyanotech Focuses Natural Astaxanthin Production on BioAstin for Human Market, Discontinues Production of NatuRose for Animal Feed Market in Strategic Move KAILUA KONA, Hawaii (March 26,
Read more →CYANCyanotech Corporation Announces Strategic Shift to Marketing-Oriented Business Model, Search for New President and CEO to Lead Effort
News Release Contact: Bruce Russell 310-559-4955 x101 brussell@cyanotech.com Announces Strategic Shift to Marketing-Oriented Business Model, Search for New President and CEO to Lead Effort Founder Gerald R. Cysewski, Ph.D. to Become Chief Scientific Officer, on Microalgae P
Read more →About Cyanotech Corporation
Headquarters73-4460 Queen Kaahumanu Highway, Suite 102, Kailua-Kona, HI, 96740, United States
BIOPHARMAWATCH ELITE
Trade the next CYAN catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $24/mo billed annually.
Cancel anytime